Asparaginase (E. coli)

Hazard statements (CLP)

H302, H317, H319, H334, H361, H362, H412

Code

Statements

H302

Harmful if swallowed

CLP CLASSIFICATION

Acute toxicity (oral), Category 4 H302 Serious eye damage/eye irritation, Category H319 2 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Reproductive toxicity, Category 2 H361 Reproductive toxicity, Additional category, H362 Effects on or via lactation Hazardous to the aquatic environment — H412 Chronic Hazard, Category 3

Hazard statements

see section 16 : H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H361 - Suspected of damaging fertility or the unborn child. H362 - May cause harm to breast-fed children. H412 - Harmful to aquatic life with long lasting effects.

Adverse physicochemical, human health and environmental effects

To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.

2.2 Label elements

Labelling according to Regulation (EC) No. 1272/2008 [CLP] Extra labelling to displayExtra classification(s) to display

Hazard pictograms

GHS07 GHS08 GHS08

Signal word

Danger

Hazardous Ingredients

lithium sulfate; Asparaginase : lithium sulfate; Asparaginase

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe mist, spray. P263 - Avoid contact during pregnancy and while nursing. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product.

Supplemental label elements

EUH032 - Contact with acids liberates very toxic gas. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml

2.3 Other hazards

No additional information available